Drug Checking | Spectra Plasmonics

Screenshot, text saying "How did you find the training?"

Stories from the Field: Drug Checking Training and Deployment Interview

Avenue B Harm Reduction talks to us about their training experience, and how they believe the Amplifi ID Drug Analysis System may support their services.

Interviews

Feb 121 min read

Company and Drug Checking Technology Information for Harm Reduction Organizations

Learn more about Spectra Plasmonics and the Amplifi ID Drug Checking Technology.

FAQ

Dec 18, 20246 min read

Visual comparison of BTMPS, mannitol, and caffeine

BTMPS Added to the Amplifi ID Detection Library

BTMPS was not designed or approved for human or animal consumption, yet has been appearing in the US drug supply.

Drug Checking

Dec 16, 20242 min read

Cover for white paper "Enhancing Drug Response: Innovations in Identifying Xylazine in Drug Mixtures"

Scientific White Paper: Identifying Xylazine in Drug Mixtures with Amplifi ID

Rates of xylazine adulteration have increased throughout the unregulated drug supply in the United States. Xylazine is non-opiate sedative often used in veterinary medicine which does not respond to Narcan (Naloxone) due to its different mechanism of action.

Drug Checking

Jul 9, 20242 min read